Shiferman Gregory L. 4
4 · Sage Therapeutics, Inc. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
Shiferman Gregory L.
See Remarks
Transactions
- Tax Payment
Common Stock
2025-02-24$7.49/sh−2,502$18,740→ 30,759 total
Footnotes (1)
- [F1]On February 24, 2025, the reporting person vested 7,500 shares of time-based restricted stock units (RSUs) granted on August 24, 2023 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vested 100% on February 24, 2025. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.